Efficacy of Autologous Bone Marrow Concentrate for Knee Osteoarthritis with and without Adipose Graft

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Centeno, Christopher ^a   Pitts, John ^a   Al Sayegh, Hasan ^a   Freeman, Michael ^b  

^a Regenerative Sciences Centeno Schultz Clinic   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW CONCENTRATE; FEMALE; HEMATOLOGICAL PROCEDURE; HUMAN; KNEE OSTEOARTHRITIS; LOWER EXTREMITY FUNCTIONAL SCALE; MAJOR CLINICAL STUDY; MALE; NUMERICAL PAIN SCALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PLATELET-RICH PLASMA CELL; SEX DIFFERENCE; TREATMENT RESPONSE; ADIPOSE TISSUE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CONFIDENCE INTERVAL; FOLLOW UP; LEG; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PATHOPHYSIOLOGY; QUESTIONNAIRE; REGISTER; STATISTICAL MODEL; TRANSPLANTATION; TREATMENT OUTCOME;

ADIPOSE TISSUE; BONE MARROW TRANSPLANTATION; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEG; LOGISTIC MODELS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; QUESTIONNAIRES; REGISTRIES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84930999694     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/370621     Document Type: Article

References (55)

1. R. C. Lawrence, D. T. Felson, C. G. Helmick et al., "Estimates of the prevalence of arthritis and other rheumatic conditions in theUnited States. Part II, " Arthritis and Rheumatism, vol. 58, no. 1, pp. 26-35, 2008.
2. A. M. Weinstein, B. N. Rome, W. M. Reichmann et al., "Estimating the burden of total knee replacement in the United States., "The Journal of Bone and Joint Surgery, vol. 95, no. 5, pp. 385-392, 2013.
3. J. N. Insall, "Historical Development, classification, and characteristics of knee prostheses, " in Surgery of the Knee, J. N. Insall, Ed., Churchill Livingstone, New York, NY, USA, 2nd edition, 1993.
4. S. M. Javad Mortazavi, H. Kakli, O. Bican, M. Moussouttas, J. Parvizi, and R. H. Rothman, "Perioperative stroke after total joint arthroplasty: prevalence, predictors, and outcome, " Journal of Bone and Joint Surgery A, vol. 92, no. 11, pp. 2095-2101, 2010.
5. M. J. Morris, R. G. Molli, K. R. Berend, and A. V. Lombardi, "Mortality and perioperative complications after unicompartmental knee arthroplasty, " Knee, vol. 20, no. 3, pp. 218-220, 2013.
6. A. Lalmohamed, P. Vestergaard, C. Cooper et al., "Timing of stroke in patients undergoing total hip replacement and matched controls: a nationwide cohort study, " Stroke, vol. 43, no. 12, pp. 3225-3229, 2012.
7. A. Lalmohamed, P. Vestergaard, C. Klop et al., "Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study, " Archives of Internal Medicine, vol. 172, no. 16, pp. 1229-1235, 2012.
8. P. R. Pinto, T. McIntyre, R. Ferrero, V. Araujo-Soares, and A. Almeida, "Persistent pain after total knee or hip arthroplasty: differential study of prevalence, nature, and impact, " Journal of Pain Research, vol. 6, pp. 691-703, 2013.
9. M. Benke and B. Shaffer, "Viscosupplementation treatment of arthritis pain, " Current Pain and Headache Reports, vol. 13, no. 6, pp. 440-446, 2009.
10. A. J. Cianflocco, "Viscosupplementation in patients with osteoarthritis of the knee, " Postgraduate Medicine, vol. 125, no. 1, pp. 97-105, 2013.
11. A. Khoshbin, T. Leroux, D. Wasserstein et al., "The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis, " Arthroscopy, vol. 29, no. 12, pp. 2037-2048, 2013.
12. F. Say, D. Gurler, K. Yener, M. Bulbul, and M. Malkoc, "Platelet-rich plasma injection ismore effective than hyaluronic acid in the treatment of knee osteoarthritis, " Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca, vol. 80, no. 4, pp. 278-283, 2013.
13. E. Kon, G. Filardo, A. Di Martino, and M. Marcacci, "Plateletrich plasma (PRP) to treat sports injuries: evidence to support its use, " Knee Surgery, Sports Traumatology, Arthroscopy, vol. 19, no. 4, pp. 516-527, 2011.
14. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells, " Science, vol. 284, no. 5411, pp. 143-147, 1999.
15. C. Lange, J. Schroeder, M. V. Lioznov, and A. R. Zander, "High-potential human mesenchymal stem cells, " Stem Cells and Development, vol. 14, no. 1, pp. 70-80, 2005.
16. "Autologous mesenchymal stem cells for treating knee osteoarthritis, " Managed Care, vol. 22, no. 8, pp. 15-16, 2013.
17. C. J. Centeno, D. Busse, J. Kisiday, C. Keohan, M. Freeman, and D. Karli, "Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologousmesenchymal stem cells, " Pain Physician, vol. 11, no. 3, pp. 343-353, 2008.
18. C. J. Centeno, "Clinical challenges and opportunities of mesenchymal stem cells in musculoskeletal medicine, " PM & R, vol. 6, no. 1, pp. 70-77, 2014.
19. Y. Qi, G. Feng, and W. Yan, "Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis, " Molecular Biology Reports, vol. 39, no. 5, pp. 5683-5689, 2012.
20. J. I. Huang, P. A. Zuk, N. F. Jones et al., "Chondrogenic potential of multipotential cells from human adipose tissue, " Plastic and Reconstructive Surgery, vol. 113, no. 2, pp. 585-594, 2004.
21. J. Pak, "Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads, " Pain Physician, vol. 15, no. 1, pp. 75-85, 2012.
22. L. Casteilla, V. Planat-Benard, P. Laharrague, and B. Cousin, "Adipose-derived stromal cells: their identity and uses in clinical trials, an update, " World Journal of Stem Cells, vol. 3, no. 4, pp. 25-33, 2011.
23. G. Desando, C. Cavallo, F. Sartoni et al., "Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit model, " Arthritis Research andTherapy, vol. 15, no. 1, article R22, 2013.
24. C. J. Centeno, D. Busse, J. Kisiday, C. Keohan, M. Freeman, and D. Karli, "Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells, " Medical Hypotheses, vol. 71, no. 6, pp. 900-908, 2008.
25. C. J. Centeno, J. R. Schultz, M. Cheever et al., "Safety and complications reporting update on the re-implantation of cultureexpanded mesenchymal stem cells using autologous platelet lysate technique, " Current Stem Cell Research and Therapy, vol. 6, no. 4, pp. 368-378, 2011.
26. C. J. Centeno, J. R. Schultz, M. Cheever, B. Robinson, M. Freeman, andW. Marasco, "Safety and complications reporting on the re-implantation of culture-expandedmesenchymal stem cells using autologous platelet lysate technique, " Current Stem Cell Research andTherapy, vol. 5, no. 1, pp. 81-93, 2010.
27. C. J. Centeno, J. R. Schultz, M. Cheever, M. Freeman, B. Robinson, and S. Faulkner, "A Case Series of Percutaneeous Treatment of Non-Union Fractures with Autologous, Culture Expanded, Bone Marrow Dervied, Mesenchymal Stem Cells and Platelet Lysate, " Bioengineering & Biomedical Science, 2011.
28. C. J. Centeno and M. D. Freeman, "Percutaneous injection of autologous, culture-expanded mesenchymal stem cells into carpometacarpal hand joints: a case series with an untreated comparison group, " Wiener Medizinische Wochenschrift, vol. 164, no. 5-6, pp. 83-87, 2013.
29. U. S. Department of Health and Human Services, Ed., Guidance for Clinical Investigators, Sponsors, and IRBs Adverse Event Reporting to IRBs-Improving Human Subject Protection, Office of the Commissioner, the Center for Drug Evaluation and Research (CDER), the Center for Biologics Evaluation and Research (CBER), the Center for Devices and Radiological health (CDRH), and the Good CLinical Practice Program (GCPP) at the Food and Drug Administration, 2009.
30. J. H. Kellgren and J. S. Lawrence, "Radiological assessment of osteo-arthrosis, " Annals of the Rheumatic Diseases, vol. 16, no. 4, pp. 494-502, 1957.
31. M. Sowers, C. A. Karvonen-Gutierrez, J. A. Jacobson, Y. Jiang, and M. Yosef, "Associations of anatomical measures from MRI with radiographically defined knee osteoarthritis score, pain, and physical functioning, " Journal of Bone and Joint Surgery A, vol. 93, no. 3, pp. 241-251, 2011.
32. S. C. Bagley, H. White, and B. A. Golomb, "Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain, " Journal of Clinical Epidemiology, vol. 54, no. 10, pp. 979-985, 2001.
33. F. I. Lewis and M. P. Ward, "Improving epidemiologic data analyses through multivariate regression modelling, " Emerging Themes in Epidemiology, vol. 10, no. 1, article 4, 2013.
34. J. M. Binkley, P. W. Stratford, S. A. Lott, and D. L. Riddle, "The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application, " Physical Therapy, vol. 79, no. 4, pp. 371-383, 1999.
35. A. M. Kelly, "The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain, " Emergency Medicine Journal, vol. 18, no. 3, pp. 205-207, 2001.
36. SAS 9. 4 Software, SAS Institute Inc, Cary, NC, USA, 2014.
37. M. R. Chen and J. L. Dragoo, "The effect of nonsteroidal antiinflammatory drugs on tissue healing, " Knee Surgery, Sports Traumatology, Arthroscopy, vol. 21, no. 3, pp. 540-549, 2013.
38. M. E. Wiggins, P. D. Fadale, H. Barrach, M. G. Ehrlich, and W. R. Walsh, "Healing characteristics of a type I collagenous structure treated with corticosteroids, " The American Journal of Sports Medicine, vol. 22, no. 2, pp. 279-288, 1994.
39. W. Tsai, C. Hsu, C. P. C. Chen, M. J. L. Chen, M. Lin, and J. S. Pang, "Ibuprofen inhibition of tendon cell migration and down-regulation of paxillin expression, " Journal of Orthopaedic Research, vol. 24, no. 3, pp. 551-558, 2006.
40. W.-C. Tsai, F.-T. Tang, M.-K. Wong, and J.-H. S. Pang, "Inhibition of tendon cell migration by dexamethasone is correlated with reduced alpha-smooth muscle actin gene expression: a potential mechanism of delayed tendon healing, " Journal of Orthopaedic Research, vol. 21, no. 2, pp. 265-271, 2003.
41. P. Randelli, F. Randelli, P. Cabitza, and L. Vaienti, "The effects of COX-2 anti-inflammatory drugs on soft tissue healing: a review of the literature, " Journal of Biological Regulators and Homeostatic Agents, vol. 24, no. 2, pp. 107-114, 2010.
42. D. Goyal, S. Keyhani, E. H. Lee, and J. H. Hui, "Evidence-based status of microfracture technique: a systematic review of level I and II studies, " Arthroscopy, vol. 29, no. 9, pp. 1579-1588, 2013.
43. B. Moradi, E. Schonit, C. Nierhoff et al., "First-generation autologous chondrocyte implantation in patients with cartilage defects of the knee: 7 to 14 years clinical and magnetic resonance imaging follow-up evaluation, " Arthroscopy, vol. 28, no. 12, pp. 1851-1861, 2012.
44. O. A. Behery, J. D. Harris, J. M. Karnes, R. A. Siston, and D. C. Flanigan, "Factors influencing the outcome of autologous chondrocyte implantation: a systematic review, " Journal of Knee Surgery, vol. 26, no. 3, pp. 203-211, 2013.
45. T. R. Liebs, W. Herzberg, A. M. Roth-Kroeger, W. Ruther, and J. Hassenpflug, "Women recover faster than men after standard knee arthroplasty, " Clinical Orthopaedics and Related Research, vol. 469, no. 10, pp. 2855-2865, 2011.
46. S. J. MacDonald, K. D. Charron, R. B. Bourne, D. D. Naudie, R. W. McCalden, and C. H. Rorabeck, "The John Insall award: gender-specific total knee replacement: prospectively collected clinical outcomes, " Clinical Orthopaedics and Related Research, vol. 466, no. 11, pp. 2612-2616, 2008.
47. P. L. Santaguida, G. A. Hawker, P. L. Hudak et al., "Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review, " Canadian Journal of Surgery, vol. 51, no. 6, pp. 428-436, 2008.
48. M. J. McElroy, R. Pivec, K. Issa, S. F. Harwin, and M. A. Mont, "The effects of obesity and morbid obesity on outcomes in TKA, "TheJournal of Knee Surgery, vol. 26, no. 2, pp. 83-88, 2013.
49. A. J. Samson, G. E. Mercer, and D. G. Campbell, "Total knee replacement in the morbidly obese: a literature review, " ANZ Journal of Surgery, vol. 80, no. 9, pp. 595-599, 2010.
50. M. S. Sridhar, C. D. Jarrett, J. W. Xerogeanes, and S. A. Labib, "Obesity and symptomatic osteoarthritis of the knee, " Journal of Bone and Joint Surgery B, vol. 94, no. 4, pp. 433-440, 2012.
51. G. N. Gillespie and A. J. Porteous, "Obesity and knee arthroplasty, " Knee, vol. 14, no. 2, pp. 81-86, 2007.
52. A. K. Amin, J. T. Patton, R. E. Cook, and I. J. Brenkel, "Does obesity influence the clinical outcome at five years following total knee replacement for osteoarthritis?" Journal of Bone and Joint Surgery B, vol. 88, no. 3, pp. 335-340, 2006.
53. G. A. Tynan, C. H. Hearnden, E. Oleszycka et al., "Endogenous oils derived from human adipocytes are potent adjuvants that promote IL-1α-dependent inflammation, " Diabetes, vol. 63, no. 6, pp. 2037-2050, 2014.
54. P. J. Belmont Jr., G. P. Goodman, B. R. Waterman, J. O. Bader, and A. J. Schoenfeld, "Thirty-day postoperative complications and mortality following total knee arthroplasty: incidence and risk factors among a national sample of 15, 321 patients, " Journal of Bone and Joint Surgery A, vol. 96, no. 1, pp. 20-26, 2014.
55. R. A. Ward and M. E. Brier, "Retrospective analyses of large medical databases: what do they tell us?" Journal of the American Society of Nephrology, vol. 10, no. 2, pp. 429-432, 1999.